CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-08 | Henn Matthew R. | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2022-07-05 | Nutritional Health LTP Fund General Partner LLC 10% owner | Purchase | +2,912,748 | $3.15 | $9.2M | 5,875,711 |
| 2022-07-05 | Nutritional Health LTP Fund General Partner LLC 10% owner | Purchase | +5,825,495 | $3.15 | $18.4M | 5,825,495 |
| 2022-07-05 | DesRosier Thomas Chief Legal Officer and EVP | Grant or award | +63,492 | $3.15 | $200K | 104,546 |
| 2022-07-05 | Henn Matthew R. | Grant or award | +47,619 | $3.15 | $150K | 47,619 |
| 2022-07-05 | Cloghessy Paula | Grant or award | +31,746 | $3.15 | $100K | 31,746 |
| 2022-07-05 | Arkowitz David Chief Financial Officer | Grant or award | +63,492 | $3.15 | $200K | 65,492 |
| 2022-07-05 | Kender Richard N Director | Grant or award | +63,492 | $3.15 | $200K | 63,492 |
| 2022-07-05 | Ege David S. | Grant or award | +31,746 | $3.15 | $100K | 31,746 |
| 2022-07-05 | Dere Willard H Director | Grant or award | +31,746 | $3.15 | $100K | 31,746 |
| 2022-07-05 | Shaff Eric D. CEO and President | Grant or award | +63,492 | $3.15 | $200K | 96,334 |
| 2022-07-05 | Zausner Meryl Director | Grant or award | +31,746 | $3.15 | $100K | 31,746 |
| 2022-07-05 | Biondi Paul Director | Grant or award | +47,619 | $3.15 | $150K | 47,619 |
| 2022-06-22 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-22 | Zausner Meryl Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-22 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-22 | Biondi Paul Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-22 | Zausner Meryl Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-22 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-06-22 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 20 of 23 · 458 trades